Rewalk Robotics Ltd (NASDAQ:RWLK) was the recipient of a large increase in short interest in the month of August. As of August 31st, there was short interest totalling 407,800 shares, an increase of 28.8% from the July 31st total of 316,700 shares. Currently, 6.2% of the shares of the company are sold short. Based on an average daily volume of 1,060,000 shares, the days-to-cover ratio is presently 0.4 days.

NASDAQ:RWLK traded down $0.09 during mid-day trading on Friday, hitting $3.20. 2,698 shares of the company’s stock traded hands, compared to its average volume of 132,380. The firm has a 50 day moving average of $3.34 and a two-hundred day moving average of $3.16. Rewalk Robotics has a 12 month low of $2.46 and a 12 month high of $25.50. The firm has a market capitalization of $23.98 million, a price-to-earnings ratio of -0.22 and a beta of 1.56. The company has a current ratio of 3.41, a quick ratio of 3.09 and a debt-to-equity ratio of 0.33.

Rewalk Robotics (NASDAQ:RWLK) last announced its quarterly earnings data on Thursday, August 8th. The medical device company reported ($0.88) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.49) by ($0.39). Rewalk Robotics had a negative return on equity of 452.23% and a negative net margin of 320.80%. The firm had revenue of $0.88 million during the quarter, compared to the consensus estimate of $2.48 million. As a group, equities research analysts expect that Rewalk Robotics will post -2.62 earnings per share for the current year.

RWLK has been the subject of several recent analyst reports. Zacks Investment Research downgraded Rewalk Robotics from a “hold” rating to a “sell” rating in a research note on Friday, August 16th. HC Wainwright upgraded Rewalk Robotics from a “neutral” rating to a “buy” rating and increased their target price for the company from $4.00 to $9.00 in a research note on Monday, June 17th. Finally, ValuEngine upgraded Rewalk Robotics from a “hold” rating to a “buy” rating in a research note on Tuesday, July 2nd.

Several hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC bought a new stake in shares of Rewalk Robotics in the 4th quarter worth approximately $49,000. FNY Investment Advisers LLC lifted its position in shares of Rewalk Robotics by 4,595.0% in the 2nd quarter. FNY Investment Advisers LLC now owns 75,120 shares of the medical device company’s stock worth $326,000 after acquiring an additional 73,520 shares during the period. Finally, Gabelli Funds LLC bought a new stake in shares of Rewalk Robotics in the 2nd quarter worth approximately $118,000. Institutional investors own 5.00% of the company’s stock.

About Rewalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

Featured Article: Dead Cat Bounce

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with's FREE daily email newsletter.